🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. Bacillus Calmette Guerin and interferon alpha

    Hospital Authority, Hong Kong

    Carcinoma of Urinary Bladder, Superficial

    phase 3 small molecule completed

    1 trial

  2. BaidI Quzhi granule

    Universal Integrated

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  3. Balcinrenone+Dapagliflozin, Balcinrenone+Dapagliflozin, Forxiga, Balcinrenone+Dapagliflozin, Forxiga 10 mg film-coated tablets

    AstraZeneca AB

    Chronic HF and comorbid impairment of kidney function who had a recent HF event to evaluate the effect of balcinrenone/dapagliflozin versus dapagliflozin alone on HF events and cardiovascular (CV) death

    phase 3 small molecule active

    1 trial

  4. Balugrastim

    Teva Pharma GmbH

    Chemotherapy-induced Neutropenia

    phase 3 mab completed

    1 trial

  5. Bardoxolone methyl

    Biogen

    Pulmonary Hypertension

    phase 3 small molecule terminated

    1 trial

  6. Baricitinib

    Eli Lilly and Company

    Systemic Lupus Erythematosus

    phase 3 small molecule terminated

    1 trial

  7. Baricitinib

    Eli Lilly and Company

    Systemic Juvenile Idiopathic Arthritis

    phase 3 small molecule active

    1 trial

  8. Bavencio 20 mg/mL concentrate for solution for infusion

    Merck Sharp and Dohme

    Solid Tumors

    phase 3 small molecule active

    1 trial

  9. Baxdrostat

    AstraZeneca

    Primary Hyperaldosteronism

    phase 3 small molecule active

    1 trial

  10. Baxdrostat

    AstraZeneca

    Uncontrolled Hypertension

    phase 3 small molecule completed

    2 trials

  11. Baxdrostat, Baxdrostat Placebo

    AstraZeneca AB

    Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.

    phase 3 small molecule active

    1 trial

  12. Baxdrostat, Baxdrostat Placebo, Baxdrostat

    AstraZeneca AB

    Uncontrolled hypertension (uTHN) defined as blood pressure that remains higher than goal levels despite patients being treated with 2 anti-hypertensive agents, including a diuretic. Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.

    phase 3 small molecule active

    1 trial

  13. Baxdrostat, Baxdrostat, Baxdrostat Placebo

    AstraZeneca AB

    Primary Aldosteronism defined by excess aldosterone secretion

    phase 3 small molecule active

    1 trial

  14. Baxdrostat, Baxdrostat, Baxdrostat, Forxiga 10 mg film-coated tablets, Baxdrostat placebo

    AstraZeneca AB

    Chronic kidney disease (CKD) and hypertension.

    phase 3 small molecule active

    1 trial

  15. Baxdrostat, Forxiga 10 mg film-coated tablets, Baxdrostat, Baxdrostat placebo

    AstraZeneca AB

    Chronic kidney disease (CKD) and hypertension.

    phase 3 small molecule active

    1 trial

  16. Beclomethasone Dipropionate 640

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  17. Beclomethasone dipropionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  18. Beclomethasone dipropionate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials

  19. Beclomethasone dipropionate

    Teva Pharma GmbH

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  20. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  21. Beclomethasone dipropionate breath-actuated inhaler

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  22. Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol

    Teva Pharma GmbH

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  23. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 3 other completed

    3 trials

  24. Behavior therapy

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 3 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources